Sensitivity Troponin I Levels and Coronary Artery Disease Severity , Progression , and Long ■ Term Outcomes

Ayman Samman Tahhan, Emory University School of Medicine Pratik Sandesara, Emory University School of Medicine Salim S. Hayek, Emory University School of Medicine Muhammad Hammadah, Emory University School of Medicine Ayman Alkhoder, Emory University School of Medicine Heval M. Kelli, Emory University School of Medicine Matthew Topel, Emory University School of Medicine Wesley T. O'Neal, Emory University School of Medicine Nima Ghasemzadeh, Emory University School of Medicine Yi-An Ko, Emory University

[1]  Yan V. Sun,et al.  Association Between High-Sensitivity Cardiac Troponin Levels and Myocardial Ischemia During Mental Stress and Conventional Stress. , 2017, JACC. Cardiovascular imaging.

[2]  M. Kanbay,et al.  Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3 , 2016, Archives of medical science : AMS.

[3]  D. Newby,et al.  High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease , 2016, Journal of the American College of Cardiology.

[4]  Deepak L. Bhatt,et al.  Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. , 2015, The New England journal of medicine.

[5]  W. Koenig,et al.  Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography. , 2014, Journal of cardiovascular computed tomography.

[6]  V. Salomaa,et al.  Comparison of Three Troponins as Predictors of Future Cardiovascular Events – Prospective Results from the FINRISK and BiomaCaRE Studies , 2014, PloS one.

[7]  A. Keech,et al.  Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease). , 2014, Journal of the American College of Cardiology.

[8]  V. Salomaa,et al.  High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. , 2014, European heart journal.

[9]  R. Schnabel,et al.  Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study , 2014, Clinical Research in Cardiology.

[10]  A. Quyyumi,et al.  Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes. , 2013, Journal of the American College of Cardiology.

[11]  T. Aw,et al.  Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[12]  L. Lind,et al.  Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. , 2013, Journal of the American College of Cardiology.

[13]  S. Solomon,et al.  Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. , 2013, Journal of the American College of Cardiology.

[14]  Fred S Apple,et al.  Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. , 2012, Clinical chemistry.

[15]  Michael C. McDaniel,et al.  Coronary angiographic scoring systems: an evaluation of their equivalence and validity. , 2012, American heart journal.

[16]  S. Blankenberg,et al.  Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. , 2011, JAMA.

[17]  A. Kastrati,et al.  High-sensitivity troponin T level and angiographic severity of coronary artery disease. , 2011, The American journal of cardiology.

[18]  S. Yusuf,et al.  High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. , 2011, Clinical chemistry.

[19]  H. White.  Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? , 2011, Journal of the American College of Cardiology.

[20]  H. Kauczor,et al.  Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque , 2010, Heart.

[21]  A. Jaffe,et al.  High-sensitive cardiac troponin I (hs-cTnI) values in patients with stable cardiovascular disease: an initial foray. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[22]  M. Schellings,et al.  The Extent of Coronary Atherosclerosis Is Associated With Increasing Circulating Levels of High Sensitive Cardiac Troponin T , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Michael J. Pencina,et al.  Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.

[24]  M. Sabatine,et al.  Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. , 2008, European heart journal.

[25]  T. Hansen,et al.  C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[26]  B. Gersh.  Relationship Between C-Reactive Protein and Subclinical Atherosclerosis: The Dallas Heart Study , 2007 .

[27]  A. Khera,et al.  Relationship Between C-Reactive Protein and Subclinical Atherosclerosis: The Dallas Heart Study , 2005, Circulation.

[28]  M. Pencina,et al.  C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. , 2005, Archives of internal medicine.

[29]  R. D. de Winter,et al.  Plaque Instability Frequently Occurs Days or Weeks Before Occlusive Coronary Thrombosis: A Pathological Thrombectomy Study in Primary Percutaneous Coronary Intervention , 2005, Circulation.

[30]  M. Caputo,et al.  Short periods of regional ischaemia and reperfusion provoke release of troponin I from the human hearts. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[31]  D. Waters,et al.  Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury in a swine model. , 1998, American journal of clinical pathology.

[32]  T. Craven,et al.  Prognostic Significance of Progression of Coronary Atherosclerosis , 1993, Circulation.

[33]  V. Fuster,et al.  Angiographic progression of coronary artery disease and the development of myocardial infarction. , 1988, Journal of the American College of Cardiology.

[34]  G. Gensini,et al.  Indications for cardiac catheterization, angiography, and coronary arteriography. , 1975, Geriatrics.